OCUGEN, INC. Total Long-Term Debt
OCUGEN, INC. (OCGN) had Total Long-Term Debt of $1.71 million as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2022-02-28
- 2021-12-31: Long-term Debt $1.71M.
- 2021-09-30: Long-term Debt $1.69M.
- 2021-06-30: Long-term Debt $1.67M.
- 2021-03-31: Long-term Debt $2.08M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2021-12-31 | $1.71M 10-K · filed 2022-02-28 | |
| 2021-09-30 | $1.69M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.67M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $2.08M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $2.06M 10-K · filed 2022-02-28 | $2.06M 10-K · filed 2021-03-19 |
| 2020-09-30 | $3.16M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $6.09M 10-Q · filed 2020-08-14 | |
| 2019-12-31 | $1.07M 10-K · filed 2021-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |